Exenatide twice-daily does not affect renal function or albuminuria compared to titrated insulin glargine in patients with type 2 diabetes mellitus: A post-hoc analysis of a 52-week randomised trial
Titel:
Exenatide twice-daily does not affect renal function or albuminuria compared to titrated insulin glargine in patients with type 2 diabetes mellitus: A post-hoc analysis of a 52-week randomised trial
Auteur:
Muskiet, M.H.A. Bunck, M.C. Heine, R.J. Cornér, A. Yki-Järvinen, H. Eliasson, B. Joles, J.A. Diamant, M. Tonneijck, L. van Raalte, D.H.